Luigia Vetrone
Papers
1
Total Citations
6
H-Index
1
About
Luigia Vetrone is a rising figure in urologic oncology, whose work is shaping the clinical integration of molecular imaging for prostate cancer management. Her research centers on the intersection of histopathology and nuclear medicine, specifically investigating how tumor biology influences the accuracy of PSMA-PET scans. In her most-cited 2024 study, she performed a detailed immunohistochemistry analysis of PSMA expression in high-risk prostate cancer biopsy specimens, directly correlating tissue-level protein presence with potential imaging outcomes. This work provides a critical, evidence-based framework for patient selection, helping to identify which men are most likely to benefit from PSMA-PET for staging and restaging. By bridging the gap between the pathologist’s microscope and the radiologist’s scan, Vetrone is refining the precision of non-invasive cancer detection. Her contributions are particularly timely, as PSMA-PET becomes a standard of care, and her insights help clinicians avoid false negatives by understanding the biological limits of the technology. With her focused, translational approach, Vetrone is establishing herself as a key voice in the personalized imaging of high-risk prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1